Display options
Share it on

Acta Naturae. 2015 Oct-Dec;7(4):142-5.

2-(2,4-Dioxy-1,2,3,4-Tetrahydropyrimidin-1-yl)-N-(4-Phenoxyphenyl)-Acetamides as a Novel Class of Cytomegalovirus Replication Inhibitors.

Acta naturae

D A Babkov, M P Paramonova, A A Ozerov, A L Khandazhinskaya, R Snoeck, G Andrei, M S Novikov

Affiliations

  1. Volgograd State Medical University, Pavshikh Bortsov Sq., 1, Volgograd 400131, Russia.
  2. Engelhardt Institute of Molecular Biology, Russian Academy of Science, Vavilov Str., 32, Moscow, 119991 , Russia.
  3. Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven B-3000, Belgium.

PMID: 26798502 PMCID: PMC4717260

Abstract

A series of novel uracil derivatives, bearing N-(4-phenoxyphenyl)acetamide moiety at N3 of a pyrimidine ring, has been synthesized. Their antiviral activity has been evaluated. It has been found that the novel compounds possess high inhibitory activity against replication of human cytomegalovirus (AD-169 and Davis strains) in HEL cell cultures. In addition, some of the derivatives proved to be inhibitory against varicella zoster virus.

Keywords: antiviral activity; human cytomegalovirus; synthesis; uracil derivatives

References

  1. Lancet Infect Dis. 2004 Dec;4(12):725-38 - PubMed
  2. Clin Microbiol Rev. 2010 Oct;23(4):689-712 - PubMed
  3. Curr Gastroenterol Rep. 2008 Aug;10(4):409-16 - PubMed
  4. Bioorg Med Chem. 2013 Jul 15;21(14):4151-7 - PubMed
  5. Transplantation. 2012 Jun 15;93(11):1075-85 - PubMed
  6. Rev Med Virol. 2007 Sep-Oct;17(5):355-63 - PubMed
  7. Infect Disord Drug Targets. 2011 Oct;11(5):475-503 - PubMed
  8. Bioorg Med Chem. 2013 Mar 1;21(5):1150-8 - PubMed
  9. Med Res Rev. 2005 Jan;25(1):1-20 - PubMed
  10. Rev Med Virol. 2010 Jul;20(4):202-13 - PubMed

Publication Types